HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roland Foisner Selected Research

lamina-associated polypeptide 2

2/2010Lamina-associated polypeptide 2alpha loss impairs heart function and stress response in mice.
11/2008Loss of nucleoplasmic LAP2alpha-lamin A complexes causes erythroid and epidermal progenitor hyperproliferation.
6/2008The LEM domain proteins emerin and LAP2alpha are dispensable for human immunodeficiency virus type 1 and murine leukemia virus infections.
4/2006Lamina-associated polypeptide 2alpha regulates cell cycle progression and differentiation via the retinoblastoma-E2F pathway.
12/2005Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roland Foisner Research Topics

Disease

9Laminopathies
01/2019 - 08/2004
6Progeria (Hutchinson Gilford Syndrome)
12/2022 - 01/2009
4Neoplasms (Cancer)
01/2014 - 03/2005
3Muscular Dystrophies (Muscular Dystrophy)
01/2015 - 05/2007
2Genomic Instability
04/2016 - 01/2015
2Premature Aging
05/2014 - 02/2010
2Carcinogenesis
01/2014 - 03/2005
2Lipodystrophy
02/2010 - 05/2007
2Retinoblastoma (Glioblastoma, Retinal)
06/2007 - 04/2006
1Fibrosis (Cirrhosis)
02/2010
1Heart Diseases (Heart Disease)
02/2010
1Heart Failure
02/2010
1Hypertrophy
02/2010
1Osteoporosis
01/2009
1Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy)
12/2008
1Infections
06/2008
1Vaccinia
04/2007
1Starvation
04/2006
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
12/2005
1Breast Neoplasms (Breast Cancer)
03/2005
1Hepatocellular Carcinoma (Hepatoma)
06/2003

Drug/Important Bio-Agent (IBA)

15LaminsIBA
01/2019 - 08/2004
8Proteins (Proteins, Gene)FDA Link
01/2014 - 03/2005
5lamina-associated polypeptide 2IBA
02/2010 - 12/2005
4ChromatinIBA
01/2019 - 01/2015
4Lamin Type A (Lamin A)IBA
01/2018 - 12/2008
3Peptides (Polypeptides)IBA
01/2018 - 01/2014
3Retinoblastoma ProteinIBA
01/2014 - 04/2006
2prelamin AIBA
03/2016 - 02/2008
2Cadherins (E-Cadherin)IBA
04/2007 - 03/2005
1MicroRNAs (MicroRNA)IBA
12/2022
1Small Interfering RNA (siRNA)IBA
03/2016
1Extracellular Matrix ProteinsIBA
10/2015
1Nuclear Proteins (Protein, Nuclear)IBA
01/2015
1MEF2 Transcription FactorsIBA
02/2010
1beta Adrenergic ReceptorsIBA
02/2010
1Transcription Factors (Transcription Factor)IBA
02/2010
1Adrenergic Agents (Adrenergic Drugs)IBA
02/2010
1emerinIBA
06/2008
1Zinc Finger E-box-Binding Homeobox 1IBA
04/2007
1PlakophilinsIBA
04/2007
1Phosphotransferases (Kinase)IBA
04/2007
1Nuclear Matrix-Associated ProteinsIBA
01/2006
13,3,5,5-tetramethyl-1-pyrroline N-oxide (TMPO)IBA
12/2005
1Thymopoietins (TP 49)IBA
12/2005
1Estrogens (Estrogen)FDA Link
06/2003
1Apolipoprotein A-I (Apolipoprotein A1)IBA
06/2003

Therapy/Procedure

1Therapeutics
02/2008